EUVIMEDEUVIMED entdecken
Multizentrische Studie

Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)

Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, Pritha Roy, Jose C Tapia, Paula Nay, Armelle Vinceneux, Felix Lefort, Simon Nannini, Adela Maria Del Carmen Randis, Natacha Naoun, Bernard Escudier und 9 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115389 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Javier Gavira und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Gustave Roussy, Paris Saclay University, Villejuif, France; Department of Medical Oncology, Institut Català d'Oncolog…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Phenylurea Compounds, Kidney Neoplasms, Quinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellPhenylurea CompoundsKidney NeoplasmsQuinolinesProtein Kinase InhibitorsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultAged, 80 and overEuropeTreatment OutcomeImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

EfficacyKidney cancerLater linesLenvatinibOutcomesReal-world dataRenal Cell CarcinomaSafety

Substanzen

lenvatinibPhenylurea CompoundsQuinolinesProtein Kinase InhibitorsImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical Oncology, Gustave Roussy, Paris Saclay University, Villejuif, France; Department of Medical Oncology, Institut Català d'Oncologia, Hospitalet de Llobregat, Spain.
  • Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Department of Medical Oncology, Gustave Roussy, Paris Saclay University, Villejuif, France.
  • Department of Clinical Oncology, Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, Wales, United Kingdom.
  • Department of Medical Oncology, Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, Wales, United Kingdom.
  • Department of Medical Oncology, Hôpital Européen Georges-Pompidou, University of Paris, Paris, France.

Zitieren

APA

Gavira, J., Auclin, E., Rey-Cardenas, M., Roy, P., Tapia, J. C., Nay, P., Vinceneux, A., Lefort, F., Nannini, S., Randis, A. M. D. C., Naoun, N., Escudier, B., Borchiellini, D., de Velasco, G., Barthelemy, P., Gross-Goupil, M., Negrier, S., Oudard, S., Frazer, R. D., …, & Flippot, R. (2025). Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115389

Vancouver

Gavira J, Auclin E, Rey-Cardenas M, Roy P, Tapia JC, Nay P, et al. Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT). European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115389

BibTeX
@article{Gavira2025,
  author = {Gavira, Javier and Auclin, Edouard and Rey-Cardenas, Macarena and Roy, Pritha and Tapia, Jose C and Nay, Paula and Vinceneux, Armelle and Lefort, Felix and Nannini, Simon and Randis, Adela Maria Del Carmen and Naoun, Natacha and Escudier, Bernard and Borchiellini, Delphine and de Velasco, Guillermo and Barthelemy, Philippe and Gross-Goupil, Marine and Negrier, Sylvie and Oudard, Stéphane and Frazer, Ricky D and Albiges, Laurence and Flippot, Ronan},
  title = {Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115389}
}
Kostenlos starten →